On 14 May 2026, the BBC reported a woman from Liverpool ended up in intensive care after injecting a weight-loss drug purchased from a “friend of a friend.” Chloe, not her real name, spent three months off work and may have sustained long-term liver damage. Her case illustrates a broader crisis around extreme dieting in Britain.
Prevalence of all eating disorders rose from 6% of the UK population in 2019 to 7.5% in 2025, according to the National Audit of Eating Disorders published in December 2025. Beat estimates at least 1.25 million people are affected, but NHS England data suggests the true figure may be between 4.17 and 5.2 million. The cost to the English economy was estimated at £8 billion in 2020.
What extreme dieting does to the body
NHS and NICE guidance recommends a moderate deficit of 500 to 600 kcal per day. Aggressive restriction – 1,000 kcal or more below daily needs – triggers serious damage. Electrolyte imbalances from low potassium and magnesium can disrupt cardiac rhythm and cause arrhythmias; Derbyshire Healthcare NHS Foundation Trust identifies electrolyte disruption as the primary medical emergency in eating disorders.
A 24-week caloric restriction study cited in StatPearls found women lost more than 16 kg with significantly decreased bone mineral density. Long-term calcium deficiency from restrictive diets is associated with osteoporosis. A 2025 BMJ Medicine study by Keele and Manchester universities found people with eating disorders were six times more likely to develop renal failure and nearly seven times more likely to develop liver disease within the first year – risks persisting for up to ten years after diagnosis. Rapid weight loss also triggers gallstones, and very low calorie diets carry the risk of refeeding syndrome.
The British Heart Foundation warns that extreme approaches – juice cleanses, elimination diets, prolonged fasting – routinely produce anaemia, fatigue, and impaired immune function. Weight loss from these methods is predominantly water and muscle, not fat.
The eating disorder crisis among young people
NHS England’s 2023 survey data shows eating disorder prevalence in children aged 11 to 16 rose from 0.5% in 2017 to 2.6% in 2023. For 17 to 19-year-olds: from 0.8% to 12.5%. Among girls aged 17 to 19, the rate reached 20.8%. Binge eating disorder accounts for 22% of cases, bulimia 19%, and OSFED 47%, according to Hay et al (2017). The National Audit found the median wait for assessment is 14 days for children but 28 days for adults. In February 2026, the Royal College of Psychiatrists revealed 16 Integrated Care Boards planned to cut children’s eating disorder services by £2.1 million.
Social media and the body image machine
A 2019 Mental Health Foundation survey found 31% of teenagers and 35% of adults felt ashamed or depressed because of body image. In subsequent research, 40% of young people reported social media images caused body image worry – rising to 54% among girls. The crisis is not abstract. As we explored in our analysis of body image and mental health, the link between appearance pressure and psychological harm is now backed by longitudinal data. A 2022 UK Parliamentary inquiry concluded pressures were “unprecedented,” with each witness reporting body image issues started in childhood. City, University of London research found appearance ideals were “narrowing” toward a “slim-thick” ideal promoted by influencer culture, with time on social media consistently linked to body dissatisfaction.
The black market for weight-loss jabs
GLP-1 receptor agonists – semaglutide (Wegovy, Ozempic), tirzepatide (Mounjaro) – have created a parallel crisis. UCL found 1.6 million UK adults used weight-loss medications in 2025. The MHRA seized over 6,500 counterfeit injections in three years, jumping from 407 in 2023 to 5,851 in 2025. In Northamptonshire, the agency raided what it described as the world’s first large-scale illegal manufacturing facilities for weight-loss jabs.
Andy Morling, head of the MHRA’s criminal enforcement unit, told the Health and Social Care Committee some counterfeit pens contained insulin instead of semaglutide – “could have killed people.” Others contained windscreen wash or no trace of the active peptide. Save Face reported steroids sold as Mounjaro and shared pens creating HIV and hepatitis risks. Karen McGonigal, a 53-year-old mother from Salford, died in May 2025 after being illegally administered semaglutide.
What the NHS actually recommends
NICE guideline NG246, updated January 2026, recommends behavioural interventions, tailored dietary advice, physical activity, and ongoing support. Very low calorie diets are only recommended under medical supervision. For pharmacological intervention, NICE recommends semaglutide and tirzepatide for people with a BMI of 35 or over with weight-related health conditions. The evidence base for sustainable approaches, as covered in our feature on healthy weight management, points consistently toward moderate change over dramatic restriction.
The core message is consistent: sustainable weight loss occurs through moderate caloric reduction, balanced nutrition, and professional support – not extreme restriction, unregulated medication, or black-market injections. The pursuit of physical perfection through extreme means is not merely ineffective. It can be lethal.
Sources
National Audit of Eating Disorders (HQIP, Dec 2025); NHS England MHCYP 2023 (July 2025); Beat, Prevalence in the UK; Keele/Manchester, Health impacts of eating disorders, BMJ Medicine (Nov 2025); NICE NG246 (Jan 2026); BHF, Extreme diets; Bolt Pharmacy (Mar 2026); BBC News (May 2026); MHRA FOI (Jan 2026); UCL weight-loss medication study (2025); Mental Health Foundation; UK Parliament Health and Social Care Committee (2022); RCPsych (Feb 2026)
